GEP20053513B - 2-Aminocarbonyl-9H-Purine Derivatives - Google Patents

2-Aminocarbonyl-9H-Purine Derivatives

Info

Publication number
GEP20053513B
GEP20053513B GEAP2001004973A GEP20053513B GE P20053513 B GEP20053513 B GE P20053513B GE AP2001004973 A GEAP2001004973 A GE AP2001004973A GE P20053513 B GEP20053513 B GE P20053513B
Authority
GE
Georgia
Prior art keywords
aminocarbonyl
purine derivatives
compounds
preparation
solvates
Prior art date
Application number
Inventor
Simon John Mantell
Peter Thomas Stephenson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0024920A external-priority patent/GB0024920D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of GEP20053513B publication Critical patent/GEP20053513B/en

Links

Abstract

1. Technical Result Reduce of side effects, increase in treatment efficiency. 2. Essence The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds. 3. Field of Application Medicine. Tables: 2
GEAP2001004973 2000-06-06 2001-06-05 2-Aminocarbonyl-9H-Purine Derivatives GEP20053513B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0014048A GB0014048D0 (en) 2000-06-06 2000-06-06 Purine derivatives
GB0018246A GB0018246D0 (en) 2000-06-06 2000-07-25 Purine derivatives
GB0024920A GB0024920D0 (en) 2000-06-06 2000-10-11 Purine derivatives

Publications (1)

Publication Number Publication Date
GEP20053513B true GEP20053513B (en) 2005-05-10

Family

ID=9893285

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP2001004973 GEP20053513B (en) 2000-06-06 2001-06-05 2-Aminocarbonyl-9H-Purine Derivatives

Country Status (15)

Country Link
CN (1) CN100374454C (en)
AP (1) AP2001002179A0 (en)
CR (1) CR6829A (en)
DO (1) DOP2001000182A (en)
EC (1) ECSP024370A (en)
GB (2) GB0014048D0 (en)
GE (1) GEP20053513B (en)
GT (1) GT200100105A (en)
IL (1) IL152783A (en)
MY (1) MY128457A (en)
PE (1) PE20020065A1 (en)
SV (1) SV2002000477A (en)
TN (1) TNSN01083A1 (en)
YU (1) YU82302A (en)
ZA (1) ZA200209875B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105481861B (en) * 2014-09-19 2018-04-17 北京普禄德医药科技有限公司 A kind of platelet aggregation inhibitor and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347512C (en) * 1998-10-16 2005-12-06 Pfizer Inc. Adenine derivatives

Also Published As

Publication number Publication date
GB0018246D0 (en) 2000-09-13
YU82302A (en) 2005-11-28
IL152783A (en) 2008-11-26
ZA200209875B (en) 2003-12-05
CN1810822A (en) 2006-08-02
GB0014048D0 (en) 2000-08-02
PE20020065A1 (en) 2002-02-12
CN100374454C (en) 2008-03-12
SV2002000477A (en) 2002-10-24
MY128457A (en) 2007-02-28
TNSN01083A1 (en) 2005-11-10
DOP2001000182A (en) 2002-08-30
CR6829A (en) 2004-03-11
GT200100105A (en) 2002-01-31
ECSP024370A (en) 2003-03-10
AP2001002179A0 (en) 2002-11-30

Similar Documents

Publication Publication Date Title
MXPA02012033A (en) 2-aminocarbonyl-9h-purine derivatives.
AP1739A (en) Azaindoles
MXPA03005464A (en) Antiviral agents.
MXPA02007942A (en) Pyrrolopyrimidinone derivatives, process of preparation and use.
PL358281A1 (en) Novel compounds
JO2339B1 (en) Benzimidazoles
HRP20031003A2 (en) 4'-substituted nukleosides
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
PL366198A1 (en) Novel compounds
MXPA04000577A (en) Dolastatin 10 derivatives.
SE0102055D0 (en) New Compounds
YU87202A (en) Arylmethylamine derivatives for use as tryptase inhibitors
BG106155A (en) Novel derivatives and analogues of galanthamin
TR200402070T4 (en) Cyclobutene-dione derivatives and their use in the treatment of arteriosclerosis
EP1419129A4 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
EP1019047A4 (en) Antithrombotic agents
MXPA02004441A (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors.
EP1027051A4 (en) Antithrombotic agents
GEP20053513B (en) 2-Aminocarbonyl-9H-Purine Derivatives
AP9801235A0 (en) Erythromycin derivatives.
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
HK1068344A1 (en) Dimeric compounds and their use as anti-viral agents
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"
IL160604A0 (en) C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals